Jing Yang1,2, Jiali Hou3, Mengxia Li4. 1. Department of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China. 2. School of Sericulture, Textile and Biomass Science, Southwest University, Chongqing, 400715, China. 3. School of Life Sciences, Chongqing University, Chongqing, 400044, China. 4. Department of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China. mengxia.li@outlook.com.
Abstract
BACKGROUND: Apolipoprotein B mRNA-editing catalytic polypeptide (APOBEC) is a family of highly efficient cytidine deaminase enzymes. APOBECs have been proven to deaminate cytidine on single-stranded DNA or RNA. Inducing the deamination of cytosine on the target gene into uracil, which exerts a variety of physiological functions, plays an important role in innate immunity, adaptive immunity, and antiviral. As the research progresses, APOBECs have been confirmed to be highly expressed in a variety of tumors, causing abnormal mutations in host genes, leading to inactivation of tumor suppressor genes or activation of proto-oncogenes, and their role in tumor development and as diagnostic and treatment markers gradually be found. CONCLUSION: This article will review the mechanism of APOBECs and their impact on tumor occurrence, development, diagnosis, and treatment, and provide a theoretical basis for future tumor treatment.
BACKGROUND: Apolipoprotein B mRNA-editing catalytic polypeptide (APOBEC) is a family of highly efficient cytidine deaminase enzymes. APOBECs have been proven to deaminate cytidine on single-stranded DNA or RNA. Inducing the deamination of cytosine on the target gene into uracil, which exerts a variety of physiological functions, plays an important role in innate immunity, adaptive immunity, and antiviral. As the research progresses, APOBECs have been confirmed to be highly expressed in a variety of tumors, causing abnormal mutations in host genes, leading to inactivation of tumor suppressor genes or activation of proto-oncogenes, and their role in tumor development and as diagnostic and treatment markers gradually be found. CONCLUSION: This article will review the mechanism of APOBECs and their impact on tumor occurrence, development, diagnosis, and treatment, and provide a theoretical basis for future tumor treatment.
Authors: Daniel L Faden; Fei Ding; Yan Lin; Shuyan Zhai; Fengshen Kuo; Timothy A Chan; Luc G Morris; Robert L Ferris Journal: Oral Oncol Date: 2019-07-30 Impact factor: 5.337
Authors: Joseph W Veldman; Julie C Aleman; Swanni T Alvarado; T Michael Anderson; Sally Archibald; William J Bond; Thomas W Boutton; Nina Buchmann; Elise Buisson; Josep G Canadell; Michele de Sá Dechoum; Milton H Diaz-Toribio; Giselda Durigan; John J Ewel; G Wilson Fernandes; Alessandra Fidelis; Forrest Fleischman; Stephen P Good; Daniel M Griffith; Julia-Maria Hermann; William A Hoffmann; Soizig Le Stradic; Caroline E R Lehmann; Gregory Mahy; Ashish N Nerlekar; Jesse B Nippert; Reed F Noss; Colin P Osborne; Gerhard E Overbeck; Catherine L Parr; Juli G Pausas; R Toby Pennington; Michael P Perring; Francis E Putz; Jayashree Ratnam; Mahesh Sankaran; Isabel B Schmidt; Christine B Schmitt; Fernando A O Silveira; A Carla Staver; Nicola Stevens; Christopher J Still; Caroline A E Strömberg; Vicky M Temperton; J Morgan Varner; Nicholas P Zaloumis Journal: Science Date: 2019-10-18 Impact factor: 47.728
Authors: Daniel L Faden; Sean Thomas; Paul G Cantalupo; Nishant Agrawal; Jeffrey Myers; Joseph DeRisi Journal: Oral Oncol Date: 2017-09-13 Impact factor: 5.337
Authors: Najwa El Kadi; Luo Wang; April Davis; Hasan Korkaya; Alexander Cooke; Varun Vadnala; Noah A Brown; Bryan L Betz; Marilia Cascalho; Gregory P Kalemkerian; Khaled A Hassan Journal: Cancer Res Date: 2018-10-17 Impact factor: 12.701
Authors: Christopher B Driscoll; Matthew R Schuelke; Timothy Kottke; Jill M Thompson; Phonphimon Wongthida; Jason M Tonne; Amanda L Huff; Amber Miller; Kevin G Shim; Amy Molan; Cynthia Wetmore; Peter Selby; Adel Samson; Kevin Harrington; Hardev Pandha; Alan Melcher; Jose S Pulido; Reuben Harris; Laura Evgin; Richard G Vile Journal: Nat Commun Date: 2020-02-07 Impact factor: 14.919
Authors: Luis M Cortez; Amber L Brown; Madeline A Dennis; Christopher D Collins; Alexander J Brown; Debra Mitchell; Tony M Mertz; Steven A Roberts Journal: PLoS Genet Date: 2019-12-16 Impact factor: 5.917
Authors: Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton Journal: Nature Date: 2013-08-14 Impact factor: 49.962
Authors: Joaquim Bellmunt; Jaegil Kim; Brendan Reardon; Júlia Perera-Bel; Anna Orsola; Alejo Rodriguez-Vida; Stephanie A Wankowicz; Michaela Bowden; Justine A Barletta; Juan Morote; Inés de Torres; Nuria Juanpere; Josep Lloreta-Trull; Silvia Hernandez; Kent W Mouw; Mary-Ellen Taplin; Paloma Cejas; Henry W Long; Eliezer M Van Allen; Gad Getz; David J Kwiatkowski Journal: Cancer Res Date: 2020-08-31 Impact factor: 13.312